If you have been reading about circadian rhythm and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-12-31. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule nuclear receptor ligand |
| Appearance | Off-white to pale yellow solid | Typical for research-grade powder |
| Solubility class | Soluble in DMSO; low water solubility | Common stock solutions use organic solvent |
| Typical stock solvent | Dimethyl sulfoxide | Used for laboratory assays |
| Common analytical method | HPLC with UV or mass detection | Used for identity and purity checks |
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
==== Australia ==== MDMA is particularly expensive in Australia, costing A$15–A$30 per tablet. In terms of purity data for Australian MDMA, the average is around 34%, ranging from less than 1% to about 85%. The majority of tablets contain 70–85 mg of MDMA. Most MDMA enters Australia from the Netherlands, the UK, Asia, and the US.
=== In English translation === Kermani, Navid (2011). The Terror of God: Attar, Job and the Metaphysical Revolt. Translated by Wieland Hoban. Cambridge, UK: Polity. ISBN 978-0-7456-4527-8. OCLC 668946700. Kermani, Navid (2015). God is Beautiful: The Aesthetic Experience of the Quran. Translated by Tony Crawford. Cambridge, UK: Polity Press. ISBN 978-0745651675. OCLC 881418248. Kermani, Navid (2016). Between Quran and Kafka: West-eastern Affinities. Translated by Tony Crawford. Cambridge, UK: Polity Press. ISBN 978-1-5095-0033-8. OCLC 940342167. Kermani, Navid (2017). Upheaval: The Refugee Trek through Europe. Translated by Tony Crawford. Cambridge, UK: Polity Press. ISBN 978-1-5095-1868-5. OCLC 982184554. Kermani, Navid (2017). Wonder Beyond Belief: On Christianity. Translated by Tony Crawford (English ed.). Cambridge, UK: Polity Press. ISBN 978-1509514847. (2018 Schlegel-Tieck Prize.) Kermani, Navid (2018). State of Emergency: Travels in a Troubled World. Translated by Tony Crawford. Cambridge, UK: Polity. ISBN 978-1-5095-1470-0. Kermani, Navid (2019). Love Writ Large. Translated by Alexander Booth. London: Seagull Books. ISBN 978-0-85742-602-4. OCLC 1051682987. Kermani, Navid (2020). Along the Trenches: A Journey through Eastern Europe to Isfahan. Translated by Tony Crawford. Cambridge, UK: Polity Press. ISBN 978-1-5095-3557-6. OCLC 1097364913. Kermani, Navid (2022). Tomorrow Is Here: Speeches. Translated by Tony Crawford. Cambridge, UK: Polity Press. ISBN 978-1-5095-5056-2. OCLC 1292971292. Kermani, Navid (2023).
==== Federal Trade Commission (FTC) ==== The Federal Trade Commission monitors the DTC testing market for deceptive marketing strategies and unsubstantiated claims, taking action against companies that make misleading representations about test accuracy, interpretation, or health benefits.
== Personal life == After raising their 6 children, James, Nancy, Betsy, Cathy, Laurie and Sally, his wife Elizabeth (Libby), a biologist by training, joined the Merrifield laboratory at Rockefeller University where she worked for over 23 years. After a long illness, R. Bruce Merrifield died on May 14, 2006, at the age of 84 in his home in Cresskill, New Jersey. At the time of his death he was survived by his wife Libby, their 6 children and 16 grandchildren. Libby died on September 13, 2017.
Sources: en.wikipedia.org
=== Quiboloy's arrest order and Duterte as KOJC administrator === On March 9, 2024, Duterte's longtime friend and Kingdom of Jesus Christ leader, Pastor Apollo Quiboloy, was ordered arrested by the United States Federal Bureau of Investigation after his conviction by a US District Court for alleged cases of sex trafficking, rape, fraud, and cash smuggling. No extradition request was received by the Marcos administration for Quiboloy's arrest, although a probe in the Senate was previously initiated on January 23 by Senator Risa Hontiveros, who invited Quiboloy to attend the hearings. Quiboloy demanded a fair trial as a requirement to attend, though this was rebuked by Hontiveros and Marcos. Claiming his life was under threat through what he described as a connivance between Marcos and the US government, Quiboloy went into hiding and designated Duterte as administrator of his ministry's properties. After Quiboloy refused to attend the hearings, Hontiveros cited him in contempt and recommended the Senate President to order his arrest. Arrest orders for Quiboloy were issued by the Pasig Regional Trial Court despite the efforts of Senators Robin Padilla, Cynthia Villar, and Bong Go to oppose the move. Four separate raids were eventually held in Quiboloy's properties in Davao City; though Quiboloy was not found, the raids were criticized by Duterte and his allies for its "excessive [and] unnecessary force" involving several units of police and military personnel "in full battle gear". KOJC members gathered in a rally in Liwasang Bonifacio calling for justice for Quiboloy.
In 2024, the Council of Europe adopted the Framework Convention on Artificial Intelligence and Human Rights, Democracy and the Rule of Law, the first legally binding international treaty governing artificial intelligence.
The structure and function of the GI tract can be described both by gross anatomy and microscopic anatomy (histology). The tract itself is divided into upper and lower tracts, and the intestines into small and large intestines.
Sources: en.wikipedia.org
Biko was commemorated in several artworks after his death. Gerard Sekoto, a South African artist based in France, produced Homage to Steve Biko in 1978, and another South African artist, Paul Stopforth, included a work entitled The Interrogators in his 1979 exhibition. A triptych, it depicted the three police officers implicated in Biko's death. Kenya released a commemorative postage stamp featuring Biko's face. Biko's death also inspired several songs, including from artists outside South Africa such as Tom Paxton and Peter Hammill. The English singer-songwriter Peter Gabriel released "Biko" in tribute to him, which was a hit single in 1980, and was banned in South Africa soon after. Along with other anti-apartheid music, the song helped to integrate anti-apartheid themes into Western popular culture. Biko's life was also commemorated through theatre. The inquest into his death was dramatised as a play, The Biko Inquest, first performed in London in 1978; a 1984 performance was directed by Albert Finney and broadcast on television. Anti-apartheid activists used Biko's name and memory in their protests; in 1979, a mountaineer climbed the spire of Grace Cathedral in San Francisco to unfurl a banner with the names of Biko and imprisoned Black Panther Party leader Geronimo Pratt on it. Following apartheid's collapse, Woods raised funds to commission a bronze statue of Biko from Naomi Jacobson. It was erected outside the front door of city hall in East London on the Eastern cape, opposite a statue commemorating British soldiers killed in the Second Boer War.
Cells containing vector with an insert may be identified using blue/white selection by growing cells in media containing an analogue of galactose (X-gal). Cells expressing β-galactosidase (therefore does not contain an insert) appear as blue colonies. White colonies would be selected as those that may contain an insert. Other commonly used reporters include green fluorescent protein and luciferase. Targeting sequence: Expression vectors may include encoding for a targeting sequence in the finished protein that directs the expressed protein to a specific organelle in the cell or specific location such as the periplasmic space of bacteria. Protein purification tags: Some expression vectors include proteins or peptide sequences that allows for easier purification of the expressed protein. Examples include polyhistidine-tag, glutathione-S-transferase, and maltose binding protein. Some of these tags may also allow for increased solubility of the target protein. The target protein is fused to the protein tag, but a protease cleavage site positioned in the polypeptide linker region between the protein and the tag allows the tag to be removed later.
==== Laboratory use ==== In the laboratory, THF is a popular solvent when its water miscibility is not an issue. It is more basic than diethyl ether and forms stronger complexes with Li+, Mg2+, and boranes. It is a popular solvent for hydroboration reactions and for organometallic compounds such as organolithium and Grignard reagents. Thus, while diethyl ether remains the solvent of choice for some reactions (e.g., Grignard reactions), THF fills that role in many others, where strong coordination is desirable and the precise properties of ethereal solvents such as these (alone and in mixtures and at various temperatures) allows fine-tuning modern chemical reactions. Commercial THF contains substantial water that must be removed for sensitive operations, e.g. those involving organometallic compounds. Although THF is traditionally dried by distillation from an aggressive desiccant such as elemental sodium, molecular sieves have been shown to be superior water scavengers.
Produced by Peter Goodchild, directed by Bryn Higgins (the mock-documentary looked like an episode of Casualty, which he would later direct), made by Stone City Films 14 July Russian Roulette, about the early warning system in operation over Russia; 25 January 1995 over the Barents Sea, an object is detected, which at first looks like a missile, but after 8 minutes falls into the sea - it was a Norwegian rocket, and the Russians had been notified of the launch weeks before, but had not told their radar units; Bruce G. Blair, a nuclear security writer from the Brookings Institution; Colonel Robert Bykov of the Strategic Rocket Forces of Russia; Alexander Pikayev of the State Duma Defence Committee; Admiral Stansfield Turner of the United States Navy; General Eugene E.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.
It binds REV-ERB alpha and REV-ERB beta and changes the expression of genes tied to metabolism and circadian rhythm. These changes can affect mitochondria and energy use in animal models. The exact chain from receptor binding to physiological outcome is still being mapped.
No reliable human trials show that SR9009 improves athletic performance. Some rodent studies report endurance changes, but these results are not proof of human benefit. Its use in sport is prohibited, and quality and safety data are lacking.
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.